tanshinone has been researched along with Benign Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 8 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, DJ; Li, J; Yu, B | 1 |
| Chen, C; Cheng, S; Hu, S; Li, S; Luo, H; Pan, W; Song, J; Yu, J; Zeng, X | 1 |
| Li, H; Li, J; Liu, C; Lu, Y; Ren, X; Sun, C; Wang, M; Zhang, W; Zhuang, J | 1 |
| Alam, SSM; Ali, S; Hoque, M; Samanta, A; Uddin, F | 1 |
| Han, B; Hu, J; Huang, J; Kai, G; Sheng, M; Sun, C; Yang, R; Zhang, J | 1 |
| Al Abdulmonem, W; Alhumaydhi, FA; Alrouji, M; Anwar, S; Atiya, A; Majrashi, TA; Shahwan, M; Shamsi, A; Sharaf, SE; Zari, A; Zari, TA | 1 |
| Alonso, MM; Córdova-Guerrero, I; Díaz-Rubio, L; Estolano-Cobián, A; Marrero, JG; Ponce, CN | 1 |
| Li, J; Li, Y; Liu, X; Ma, Z; Wu, Z; Zou, H | 1 |
| Aras, A; Farooqi, AA; Khalid, S; Lin, X; Ozbey, U; Qureshi, MZ; Romero, MA | 1 |
| Chang, CC; Ho, TF; Huang, LR; Lai, JS; Liao, EC; Lin, JY; Lu, CH; Ma, SW; Tsai, CS | 1 |
| Jiang, S; Li, K; Sun, X; Wang, M; Wang, Q; Wang, S; Zhang, C; Zhu, R | 1 |
| Li, JX; Miao, ZH; Wang, Y; Wang, YQ | 1 |
| Song, F; Wang, J; Wu, C; Yin, Y; Yue, W; Zhong, W | 1 |
| Kapoor, S | 1 |
| Chang, DC; Feng, C; Le, XF; Luo, HW; Luo, KQ; Tian, HL; Xu, NN; Yu, T; Zhou, LY | 1 |
| Tian, XH; Wu, JH | 1 |
| Jiang, C; Jiang, P; Kim, SH; Lü, J; Ye, M; Zhang, Y | 1 |
| Song, Y; Su, L; Zeng, Y; Zhang, Z | 1 |
10 review(s) available for tanshinone and Benign Neoplasms
| Article | Year |
|---|---|
Annual review of LSD1/KDM1A inhibitors in 2020.
Topics: Antineoplastic Agents, Phytogenic; Enzyme Inhibitors; Histone Demethylases; Humans; Molecular Structure; Neoplasms | 2021 |
Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
Topics: Abietanes; Apoptosis; Humans; Neoplasms; Phosphatidylinositol 3-Kinases; Salvia miltiorrhiza | 2022 |
Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.
Topics: Abietanes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Male; Neoplasms; Phosphatidylinositol 3-Kinases; Signal Transduction | 2023 |
Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms.
Topics: Abietanes; Adjuvants, Immunologic; Drugs, Chinese Herbal; Humans; Neoplasms; Salvia miltiorrhiza; Tumor Microenvironment | 2024 |
Tanshinones and their Derivatives: Heterocyclic Ring-Fused Diterpenes of Biological Interest.
Topics: Abietanes; Antineoplastic Agents; Diterpenes; Drug Carriers; Drugs, Chinese Herbal; Humans; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Salvia miltiorrhiza | 2021 |
Roles of plant-derived bioactive compounds and related microRNAs in cancer therapy.
Topics: Abietanes; Humans; MicroRNAs; Molecular Structure; Neoplasms; Phytochemicals; Plants | 2021 |
Regulation of signaling pathways by tanshinones in different cancers.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Drug Evaluation, Preclinical; Humans; MAP Kinase Signaling System; Matrix Metalloproteinases; Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; TOR Serine-Threonine Kinases | 2017 |
Tanshinone derivatives: a patent review (January 2006 - September 2012).
Topics: Abietanes; Animals; Atherosclerosis; Cardiovascular Diseases; Drug Design; Drugs, Chinese Herbal; Humans; Neoplasms; Neurodegenerative Diseases; Patents as Topic; Prodrugs; Solubility | 2013 |
Tanshinones: sources, pharmacokinetics and anti-cancer activities.
Topics: Abietanes; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Humans; Neoplasms; Neovascularization, Pathologic; Salvia miltiorrhiza | 2012 |
[Advance of study on apoptosis inducer of several types of natural drug].
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Emodin; Flavones; Humans; Neoplasms; Phenanthrenes; Saponins | 2007 |
8 other study(ies) available for tanshinone and Benign Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and evaluation of proliferation inhibitory activity of novel L-shaped ortho-quinone analogs as anticancer agents.
Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Neoplasms; Quinones; Structure-Activity Relationship | 2021 |
Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
Topics: Alzheimer Disease; Humans; Molecular Docking Simulation; Neoplasms; Phytochemicals; Proto-Oncogene Proteins c-fyn; Tyrosine | 2023 |
Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen).
Topics: Abietanes; Amino Acid Chloromethyl Ketones; Apoptosis; Caspase Inhibitors; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Humans; Inhibitory Concentration 50; Neoplasms; Phenanthrenes; Phenanthrolines; Plant Extracts; Poly(ADP-ribose) Polymerases; Salvia miltiorrhiza; TNF-Related Apoptosis-Inducing Ligand | 2013 |
The triplet state of tanshinone I and its synergic effect on the phototherapy of cancer cells with curcumin.
Topics: Abietanes; Antineoplastic Agents; Curcumin; Drug Synergism; Drugs, Chinese Herbal; Energy Transfer; Humans; Lasers; Molecular Structure; Neoplasms; Photolysis; Phototherapy; Salvia miltiorrhiza; Tumor Cells, Cultured | 2015 |
Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Aorta; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Chickens; Chorioallantoic Membrane; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine | 2015 |
A simply triggered peptide-based hydrogel as an injectable nanocarrier of tanshinone IIA and tanshinones.
Topics: A549 Cells; Abietanes; Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Cell Survival; Delayed-Action Preparations; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections; Models, Molecular; Nanostructures; Neoplasms; Oligopeptides | 2017 |
Tanshinone IIA: a potent, natural anti-carcinogenic agent for the management of systemic malignancies.
Topics: Abietanes; Anticarcinogenic Agents; Humans; Medical Oncology; Medicine, Chinese Traditional; Neoplasm Metastasis; Neoplasms; Phenanthrenes | 2009 |
A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Proliferation; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Doxorubicin; Female; HeLa Cells; Hep G2 Cells; HL-60 Cells; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasms; Paclitaxel; Phenanthrenes; Propyl Gallate; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptor, ErbB-2; Solubility; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |